Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
8.16
-0.52 (-5.99%)
Sep 15, 2026, 4:00 PM EDT - Market closed
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $648.15 million as of September 15, 2026. Its market cap has decreased by -22.84% in one year.
Market Cap
648.15M
Enterprise Value
1.02B
1-Year Change
-22.84%
Ranking
Category
Stock Price
$8.16
ChartMarket Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $648.15M, an increase of 22.96%. That is a compound annual growth rate of 3.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 648.15M | -45.08% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 710.00M |
| Sagimet Biosciences | 676.29M |
| MiMedx Group | 666.13M |
| Verastem | 662.92M |
| Oculis Holding AG | 651.89M |
| AgomAb Therapeutics NV | 643.18M |
| BlossomHill Therapeutics | 639.23M |
| Altimmune | 636.07M |